Tools4Patient: Placebell placebo-response technology
Tools4Patient has released data demonstrating how its Placebell technology predicted placebo response in a recent Phase II randomized, controlled trial for osteoarthritis. The company applied a chronic-pain model built by meta-analysis including data from 211 placebo-treated patients from several studies; results showed a reduction in data variability between 20% and 35% percent in both placebo-treated patients and all patients.
“These results highlight the impact and applicability of Tools4Patient’s approach in clinical development and allowed the sponsor to make thorough conclusions about the study results,” said Alvaro Pereira, chief scientific officer of Tools4Patient. “With our Placebell product, for the first time, we are now able to gain insight into placebo response in drug treated as well as placebo treated patients.”
